GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » Moat Score

Prestige Consumer Healthcare (FRA:PBV) Moat Score : 5/10 (As of Jun. 30, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Moat Score?

Prestige Consumer Healthcare has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Prestige Consumer Healthcare has Narrow Moat: Prestige Consumer Healthcare Inc has a solid narrow moat due to its strong brand portfolio and customer loyalty in the consumer healthcare sector. It benefits from economies of scale and some pricing power. However, the competitive landscape and lack of significant regulatory barriers limit its moat strength.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Prestige Consumer Healthcare might have Narrow Moat - Solid narrow moat.

Competitive Comparison of Prestige Consumer Healthcare's Moat Score

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Consumer Healthcare's Moat Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Moat Score distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's Moat Score falls into.


;
;

Prestige Consumer Healthcare  (FRA:PBV) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Prestige Consumer Healthcare Moat Score Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Consumer Healthcare Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » Moat Score
Comparable Companies
PRGO ALKS ALVO AMRX BGM LNTH KNSA BCRX SUPN NDOI ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
PBH:USA
Address
660 White Plains Road, Tarrytown, NY, USA, 10591
Website
https://www.prestigebrands.com
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Prestige Consumer Healthcare Headlines

No Headlines